James Mahon
Impact in
- Pharmacy top 5%
- Infant Health and Development
-
- Food Allergy and Anaphylaxis Research
Papers in
-
- Inhalation and Respiratory Drug Delivery 2
- Oncology 4
- Co-authors
- Angela Boland (15 shared papers)Y Dündar (9 shared papers)Sophie Beale (13 shared papers)Nick Hex (4 shared papers)Eleanor Kotas (11 shared papers)Mike Baxter (2 shared papers)Chris Bartlett (1 shared paper)Yevgeniy Samyshkin (1 shared paper)
- Journals
- Health Technology Assessment (8 papers)Diabetic Medicine (2 papers)BMJ Open (2 papers)Alcohol and Alcoholism (1 paper)The European Journal of Health Economics (1 paper)
- Partner nations
- United KingdomUnited StatesNetherlands
In The Last Decade
James Mahon
29 papers receiving 572 citations
Peers
Comparison fields: 5 of 91
- Pharmacy 35
- Immunology and Allergy 30
- Endocrinology, Diabetes and Metabolism 81
- Gastroenterology 22
- Family Practice 7
Countries citing papers authored by James Mahon
This map shows the geographic impact of James Mahon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Mahon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Mahon more than expected).
Fields of papers citing papers by James Mahon
This network shows the impact of papers produced by James Mahon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Mahon. The network helps show where James Mahon may publish in the future.
Co-authors
The 25 scholars most cited alongside James Mahon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 100 | |
| 2 | 2015 | 59 | |
| 3 | 2012 | 56 | |
| 4 | 2017 | 46 | |
| 5 | 2020 | 34 | |
| 6 | 2014 | 33 | |
| 7 | 2017 | 32 | |
| 8 | 2016 | 28 | |
| 9 | 1998 | 27 | |
| 10 | 2016 | 25 | |
| 11 | 2019 | 23 | |
| 12 | 2019 | 18 | |
| 13 | 2020 | 17 | |
| 14 | Pembrolizumab for untreated PD-L1 positive metastatic non-small cell lung cancer | 2016 | 15 |
| 15 | 2022 | 14 | |
| 16 | 2014 | 13 | |
| 17 | 2016 | 9 | |
| 18 | 2016 | 8 | |
| 19 | 2018 | 7 | |
| 20 | 2023 | 6 |
About James Mahon
James Mahon is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Surgery, Public Health, Environmental and Occupational Health and Pharmacy, having authored 34 papers that have together received 596 indexed citations. Recurring topics across this work include Diabetes Management and Research (2 papers), Inhalation and Respiratory Drug Delivery (2 papers), Glaucoma and retinal disorders (2 papers), Infant Health and Development (2 papers), Atrial Fibrillation Management and Outcomes (2 papers), Corneal surgery and disorders (2 papers), Obesity, Physical Activity, Diet (1 paper) and Patient Safety and Medication Errors (1 paper). The work is most often cited by research in Pharmacy (35 citations), Immunology and Allergy (30 citations), Endocrinology, Diabetes and Metabolism (81 citations), Gastroenterology (22 citations) and Family Practice (7 citations). James Mahon has collaborated with scholars based in United Kingdom, United States and Netherlands. Frequent co-authors include Angela Boland, Y Dündar, Sophie Beale, Nick Hex, Eleanor Kotas, Mike Baxter, Chris Bartlett, Yevgeniy Samyshkin, Hannah Wood and Julie Glanville. Their work appears in journals such as Health Technology Assessment, Diabetic Medicine, BMJ Open, Alcohol and Alcoholism and The European Journal of Health Economics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.